Hyperleukocytosis, leukostasis and leukapheresis: Practice management

Blood Reviews

Volumn 26, Issue 3, 2012, Pages 117-122

  Ganzel, Chezi ^a   Becker, Joanne ^b   Mintz, Paul D ^c   Lazarus, Hillard M ^d   Rowe, Jacob M ^a,e  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Hyperleukocytosis; Leukapheresis; Leukostasis

Indexed keywords

CALCIUM; CITRATE SODIUM; DEXAMETHASONE; HETASTARCH; HYDROXYUREA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; BLOOD VISCOSITY; BLOOD VOLUME; CALCIUM SUPPLEMENTATION; CANCER MORTALITY; CENTRAL NERVOUS SYSTEM; CHRONIC MYELOID LEUKEMIA; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; HYPERLEUKOCYTOSIS; HYPOCALCEMIA; INDUCTION CHEMOTHERAPY; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOSTASIS; PATHOPHYSIOLOGY; PHLEBOTOMY; PRIORITY JOURNAL; PROGNOSIS; SUPPLEMENTATION; SYMPTOMATOLOGY; TREATMENT INDICATION; VASCULAR ACCESS;

ACUTE DISEASE; HUMANS; HYDROXYUREA; INDUCTION CHEMOTHERAPY; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOSTASIS; LUNG; PROGNOSIS; TREATMENT OUTCOME;

EID: 84859213750     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2012.01.003     Document Type: Article

References (50)

1. Cuttner J., Conjalka M.S., Reilly M., Goldberg J., Reisman A., Meyer R.J., et al. Association of monocytic leukemia in patients with extreme leukocytosis. Am J Med 1980, 69:555-558.
2. Goldstone A.H., Richards S.M., Lazarus H.M., Tallman M.S., Buck G., Fielding A.K., et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008, 111:1827-1833.
3. Johansson B., Moorman A.V., Haas O.A., Watmore A.E., Cheung K.L., Swanton S., et al. Hematologic malignancies with t(4;11)(q21;q23)-a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants. Leukemia 1998, 12:779-787.
4. Lestingi T.M., Hooberman A.L. Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematol Oncol Clin North Am 1993, 7:161-175.
5. Porcu P., Cripe L.D., Ng E.W., Bhatia S., Danielson C.M., Orazi A., et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000, 39:1-18.
6. Dixit A., Chatterjee T., Mishra P., Kannan M., Choudhry D.R., Mahapatra M., et al. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy. Clin Appl Thromb Hemost 2007, 13:292-298.
7. Vaughan W.P., Kimball A.W., Karp J.E., Dragon L.H., Burke P.J. Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts. Cancer Treat Rep 1981, 65:1007-1013.
8. Lowenberg B., Suciu S., Archimbaud E., Ossenkoppele G., Verhoef G.E., Vellenga E., et al. Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group. Blood 1997, 90:2952-2961.
9. Hug V., Keating M., McCredie K., Hester J., Bodey G.P., Freireich E.J. Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer 1983, 52:773-779.
10. Dutcher J.P., Schiffer C.A., Wiernik P.H. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987, 5:1364-1372.
11. Greenwood M.J., Seftel M.D., Richardson C., Barbaric D., Barnett M.J., Bruyere H., et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma 2006, 47:1245-1252.
12. Hoelzer D., Thiel E., Loffler H., Buchner T., Ganser A., Heil G., et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988, 71:123-131.
13. Hunault M., Harousseau J.L., Delain M., Truchan-Graczyk M., Cahn J.Y., Witz F., et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood 2004, 104(10):3028-3037.
14. Rowe J.M., Buck G., Burnett A.K., Chopra R., Wiernik P.H., Richards S.M., et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005, 106:3760-3767.
15. Grund F.M., Armitage J.O., Burns P. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch Intern Med 1977, 137:1246-1247.
16. Schwartz J.H., Cannellos G.P. Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia. Blood 1975, 46:11-16.
17. Piro E., Carillio G., Levato L., Kropp M., Molica S. Reversal of leukostasis-related pulmonary distress syndrome after leukapheresis and low-dose chemotherapy in acute myeloid leukemia. J Clin Oncol 2011, 29:e725-e726.
18. Gartrell K., Rosenstrauch W. Hypoxaemia in patients with hyperleukocytosis: true or spurious, and clinical implications. Leuk Res 1993, 17:915-919.
19. Mataix R., Gomez-Casares M.T., Campo C., Jimenez S., Malcorra J.J. Acute leg ischaemia as a presentation of hyperleukocytosis syndrome in acute myeloid leukaemia. Am J Hematol 1996, 51:250.
20. Murray J.C., Dorfman S.R., Brandt M.L., Dreyer Z.E. Renal venous thrombosis complicating acute myeloid leukemia with hyperleukocytosis. J Pediatr Hematol Oncol 1996, 18:327-330.
21. Choo-Kang L.R., Jones D.M., Fehr J.J., Eskenazi A.E., Toretsky J.A. Cerebral edema and priapism in an adolescent with acute lymphoblastic leukemia. Pediatr Emerg Care 1999, 15:110-112.
22. McKee L.C., Collins R.D. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Med (Baltim) 1974, 53:463-478.
23. Lowe E.J., Pui C.H., Hancock M.L., Geiger T.L., Khan R.B., Sandlund J.T. Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer 2005, 45:10-15.
24. Meckenstock G., Gattermann N., Schneider W., Siebler M. The leukostasis syndrome with a cerebral infarct in rapidly progressing chronic lymphatic leukemia. Dtsch Med Wochenschr 1991, 116:1388-1392.
25. Blaha M., Jebavy L., Maly J., Filip S., Kmonicek M., Siroky O. Treatment of the leukostasis syndrome in chronic lymphadenosis using leukapheresis. Vnitr Lek 1993, 39:788-792.
26. Durzynski T., Konopka L., Traczyk Z. Leukostasis syndrome in a case of chronic lymphocytic leukemia. Pol Merkur Lekarski 1999, 6:30-31.
27. Cukierman T., Gatt M.E., Libster D., Goldschmidt N., Matzner Y. Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein. Leuk Lymphoma 2002, 43:1865-1868.
28. Lichtman M.A., Rowe J.M. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood 1982, 60:279-283.
29. Stucki A., Rivier A.S., Gikic M., Monai N., Schapira M., Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001, 97:2121-2129.
30. Novotny J.R., Muller-Beissenhirtz H., Herget-Rosenthal S., Kribben A., Duhrsen U. Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome. Eur J Haematol 2005, 74:501-510.
31. Piccirillo N., Laurenti L., Chiusolo P., Sora F., Bianchi M., De Matteis S., et al. Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis. Am J Hematol 2009, 84:381-382.
32. Chang M.C., Chen T.Y., Tang J.L., Lan Y.J., Chao T.Y., Chiu C.F., et al. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. Am J Hematol 2007, 82:976-980.
33. Flasshove M., Schuette J., Sauerwein W., Hoeffken K., Seeber S. Pulmonary and cerebral irradiation for hyperleukocytosis in acute myelomonocytic leukemia. Leukemia 1994, 8:1792.
34. Powell B.L., Gregory B.W., Evans J.K., White J.C., Lyerly E.S., Chorley H.M., et al. Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemia. Leukemia 1991, 5:1037-1042.
35. McLeod B.C., Strauss R.G., Ciavarella D., Gilcher R.O., Kasprisin D.O., Kiprov D.D., et al. Management of hematological disorders and cancer. J Clin Apher 1993, 8:211-230.
36. Shelat S.G. Practical considerations for planning a therapeutic apheresis procedure. Am J Med 2010, 123:777-784.
37. Vahdat L., Maslak P., Miller W.H., Eardley A., Heller G., Scheinberg D.A., et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994, 84:3843-3849.
38. Fortuny I.E., Hadlock D.C., Kennedy B.J., Theologides A., McCullough J. The role of continuous flow centrifuge leucapheresis in the management of chronic lymphocytic leukaemia. Br J Haematol 1976, 32:609-615.
39. Goldfinger D., Capostagno V., Lowe C., Sacks H.J., Gatti R.A. Use of long-term leukapheresis in the treatment of chronic lymphocytic leukemia. Transfusion 1980, 20:450-454.
40. Hadlock D.C., Fortuny I.E., McCullough J., Kennedy B.J. Continuous flow centrifuge leucapheresis in the management of chronic myelogenous leukaemia. Br J Haematol 1975, 29:443-453.
41. Strobl F.J., Voelkerding K.V., Smith E.P. Management of chronic myeloid leukemia during pregnancy with leukapheresis. J Clin Apher 1999, 14:42-44.
42. Ali R., Ozkalemkas F., Ozkocaman V., Ozcelik T., Ozan U., Kimya Y., et al. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature. Jpn J Clin Oncol 2004, 34:215-217.
43. Fitzgerald D., Rowe J.M., Heal J. Leukapheresis for control of chronic myelogenous leukemia during pregnancy. Am J Hematol 1986, 22:213-218.
44. Giles F.J., Shen Y., Kantarjian H.M., Korbling M.J., O'Brien S., Anderlini P., et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001, 42:67-73.
45. Bug G., Anargyrou K., Tonn T., Bialleck H., Seifried E., Hoelzer D., et al. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion 2007, 47:1843-1850.
46. Thiebaut A., Thomas X., Belhabri A., Anglaret B., Archimbaud E. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol 2000, 79:501-506.
47. De Santis G.C., de Oliveira L.C., Romano L.G., Almeida Prado B.D., Simoes B.P., Rego E.M., et al. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia. J Clin Apher 2011, 26:181-185.
48. Porcu P., Danielson C.F., Orazi A., Heerema N.A., Gabig T.G., McCarthy L.J. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 1997, 98:433-436.
49. Tan D., Hwang W., Goh Y.T. Therapeutic leukapheresis in hyperleukocytic leukaemias-the experience of a tertiary institution in Singapore. Ann Acad Med Singapore 2005, 34:229-234.
50. Piro E., Carillio G., Levato L., Kropp M., Monica S. Reversal of leukostasis-related pulmonary distress syndrome after leukapheresis and low-dose chemotherapy in acute myeloid leukemia. J Clin Oncol 2011, 29:e725-e726.